Provider
QP73-18 Taft Hartley Third Party Administrators and Remote Processing Claims Delays
Program effective Date: Aug 28, 2018
Documents & Forms Results
Displaying 2791 - 2800 of 3159 results
Provider
QP74-18 Pharmacy Benefit Update - New Drug-Related Prior Authorization Criteria: Elmiron (pentosane polysulfate sodium)
Program effective Date: Aug 28, 2018
Provider
QP71-18 Pharmacy Benefit Update - New Drug-Related Step Therapy with Quantity Limit Criteria: Sodium-Glucose Co-Transporter 2 (SGLT-2) Inhibitors
Program effective Date: Aug 21, 2018
Provider
QP69-18 Universal Pharmacy Policy for Minnesota Health Care Programs Subscribers - Morphine Equivalent Dose (MED) Limit Update
Program effective Date: Aug 21, 2018
Provider
QP65-18 Pharmacy Benefit Update - New Drug-Related Prior Authorization with Quantity Limit Criteria: Jynarque (tolvapin)
Program effective Date: Aug 21, 2018
Provider
QP66-18 Pharmacy Benefit Update - New Drug-Related Prior Authorization with Quantity Limit Criteria: Noctiva (desmopressin acetate)
Program effective Date: Aug 21, 2018
Provider
QP67-18 Pharmacy Benefit Exclusion for Alferon N (interferon alpha-n3), Cytovene (ganciclovir), Foscarvir (foscarnet), Prevymis (letermovir), Trogarzo (ibalizu,ab-uiyk), Vistide (cidofovir) and Zovirax (actclovir)
Program effective Date: Aug 21, 2018
Provider
QP72-18 Pharmacy Benefit Update - New Drug-Related Step Therapy with Quantity Limit Criteria: Dipeptidyl Peptidase - 4 (DPP-4) Inhibitors
Program effective Date: Aug 21, 2018
Provider
QP68-18 Site of Care Drug Infusion/Injection Program
Program effective Date: Aug 21, 2018
Provider
QP70-18 Pharmacy Benefit Exclusion for Alferon N (interferon alpha-n3) and Lanoxin (digoxin) Injection for Minnesota Health Care Programs Subscribers
Program effective Date: Aug 21, 2018